Skip to main content

Table 5 Toxicity

From: NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice

AE nab-P + Gem

Grade 3 hematologic AE

no (%)

 Anemia

3 (7.3 %)

 Neutropenia

10 (24.3 %)

 Trombocytopenia

5 (12.1 %)

Grade 3 non hematologic AE

no (%)

 Fatigue

6 (14.6 %)

 Peripheral Neuropathy

5 (12.2 %)

 Diarrhea

4 (9.7 %)

 Nausea

2 (4.9 %)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us